Mechanism Clinical Trials

28 recruitingLast updated: May 11, 2026

There are 28 actively recruiting mechanism clinical trials across 16 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2. Top locations include Chapel Hill, North Carolina, United States, Bethesda, Maryland, United States, Ardmore, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


Mechanism Trials at a Glance

28 actively recruiting trials for mechanism are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Chapel Hill, Bethesda, and Ardmore. Lead sponsors running mechanism studies include National Institute of Mental Health (NIMH), Centre Hospitalier Universitaire de Besancon, and Barts & The London NHS Trust.

Browse mechanism trials by phase

Treatments under study

About Mechanism Clinical Trials

Looking for clinical trials for Mechanism? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mechanism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mechanism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+18 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting

TDM for Optimized Outcome in Patients With mRCC.

Renal Cell Carcinoma MetastaticKidney CancerDrug Toxicity+2 more
Niels Fristrup200 enrolled1 locationNCT04659343
Recruiting
Phase 2

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908
Recruiting

Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens

Host Defense Mechanisms
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT00339287
Recruiting
Phase 3

A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

Molecular Mechanisms of Pharmacological ActionPeripheral Nervous System AgentsNeurotransmitter Agents+7 more
Merz North America, Inc.300 enrolled28 locationsNCT07122193
Recruiting
Phase 3

A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

Molecular Mechanisms of Pharmacological ActionPeripheral Nervous System AgentsNeurotransmitter Agents+7 more
Merz Aesthetics GmbH300 enrolled26 locationsNCT07210463
Recruiting
Not Applicable

Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

Cognitive DysfunctionPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)+3 more
Leeds Beckett University70 enrolled1 locationNCT07073781
Recruiting
Not Applicable

Dental-Child Interaction Training

Behavior and Behavior MechanismsChild Behavior
University of Florida264 enrolled4 locationsNCT06138405
Recruiting
Not Applicable

Novel Personalised Nutrition Intervention With Tailored Behavioural Support

Behavior ChangeBehavior Change InterventionsDietary Behaviour+3 more
University College Dublin66 enrolled1 locationNCT07417254
Recruiting

Mechanism of TIPS to Improve Sarcopenia

SarcopeniaCirrhosisMechanism
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology132 enrolled1 locationNCT06794853
Recruiting
Not Applicable

The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults

Brain ActivityCognitionBrain Aging+2 more
University of Oklahoma30 enrolled1 locationNCT07209683
Recruiting
Not Applicable

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Arterial Occlusive DiseasesCardiovascular DiseasesCoronary Disease+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS576 enrolled1 locationNCT06535568
Recruiting

The Effect of Mobile Devices on the Development and Health of Young Children

Behavior and Behavior MechanismsCognitionPhysical Health+4 more
Sheffield Hallam University874 enrolled2 locationsNCT06810570
Recruiting
Phase 4

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

ConfusionCognitive DysfunctionMolecular Mechanisms of Pharmacological Action+14 more
Sunnybrook Health Sciences Centre2,400 enrolled8 locationsNCT04289142
Recruiting
Not Applicable

Substrate Remodelling and Targeted Ablation in AF

Atrial Fibrillation (AF)Catheter AblationAtrial Fibrillation Mechanisms+1 more
Barts & The London NHS Trust160 enrolled1 locationNCT07047235
Recruiting
Not Applicable

Interventions in Mathematics and Cognitive Skills

Cognitive ChangeCognitive DysfunctionDecision Making+25 more
Stanford University180 enrolled1 locationNCT05201534
Recruiting
Phase 1

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

MelanomaNeoplasmsNeoplasms by Site+7 more
Yana Najjar50 enrolled2 locationsNCT04572451
Recruiting
Not Applicable

Validation of a Making Decision Hybrid (Ecologic and Virtual) Task

Healthy VolunteersBehavior and Behavior Mechanisms
Centre Hospitalier Universitaire de Besancon180 enrolled1 locationNCT06337500
Recruiting
Not Applicable

Medication Adherence Program

HypertensionBehavior and Behavior MechanismsMedication Adherence
Tulane University402 enrolled5 locationsNCT05183763
Recruiting
Phase 4

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Breast CancerHeart FailureBreast Diseases+10 more
Silesian Centre for Heart Diseases600 enrolled4 locationsNCT05465031